Skip to main content

2 Result(s)

within Colin Kunzweiler Remove this filter

and

  1. Article

    Open Access

    Dosing Patterns of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab in the United States: A Retrospective Claims-Based Analysis

    Complement factor 5 inhibitors eculizumab and, recently, ravulizumab are standard therapies for paroxysmal nocturnal hemoglobinuria (PNH). However, some patients experience suboptimal response and may benefit ...

    Wendy Y. Cheng, Jesse Fishman, Mihran Yenikomshian, Malena Mahendran… in Advances in Therapy (2024)

    Download PDF (624 KB) View Article

  2. Article

    Open Access

    Literature Review of Fatigue Scales and Association with Clinically Meaningful Improvements in Outcomes Among Patients With and Without Paroxysmal Nocturnal Hemoglobinuria

    Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder characterized by anemia and debilitating fatigue. Limited evidence characterizes the association between hemoglobin, an indicator of anemia an...

    Sangeeta Krishnan, Sujata Sarda, Colin Kunzweiler, Melody Wu… in Advances in Therapy (2022)

    Download PDF (459 KB) View Article